Conference Programme
Maximising Returns from Life Science Innovation
3 December 2025
Maximising Returns from Life Science Innovation
Programme
The 2025 Keynote Programme at Genesis will explore the exciting potential offered by innovation in life sciences offers to address global health, economic and sustainability challenges. Whilst the sessions will also discuss how the barriers to progress can be defeated through creative thinking in R&D, collaboration, investment, and patient access to translate the golden triangle of ‘technology-people-money’ into value creation for all stakeholders.
Draft Keynote Programme
Registration
Welcome from One Nucleus
Tony Jones, CEO, One Nucleus
SESSION 1 – Money & Deals
Keynote Address: Winners & Losers 2025
Mike Ward, Global Head of Life Sciences Thought Leadership, Clarivate
Changeover Video
Keynote Panel: The Changing Life Science Investment Landscape
- With larger deal sizes, is the gap between the haves and have nots widening?
- Innovative business models vs investor appetite
- Does founder diversity bring investment opportunity diversity?
- Are capital pools on the move?
Coffee Break
SESSION 2 – People
Fireside Chat: Amplifying the Patient Voice
Changeover Video
Keynote Panel: Being Patient-Centric: Lessons from Rare Diseases R&D
- Patient engagement and access
- Utilising Real-World-Evidence and Experience in R&D
- Clinical trial design
- Innovative partnerships
Changeover Video
Fireside Chat: “Investing in Rare Diseases?”
Lunch Break
SESSION 3 – Technology & Innovation
Keynote Panel: Technologies for Impact?
- Which technologies are exciting the life science R&D community?
- Is all innovation now inter-disciplinary?
- How are the biggest fears of innovation being addressed?
- What constitutes validation for investors and R&D partners?
Changeover Video
Fireside Chat: What Comprises an Innovation-friendly Environment?
Changeover Video
Keynote Panel: How to Separate on Good Terms If Things Don’t Work
- Encountering a roadblock
- Communicating the need to stop
- Resolution options
- Being prepared
Coffee Break
SESSION 4 – It’s Genesis #25 – Looking Forward and Back
Keynote Panel: How Will New Medicines Be Developed and Paid For in 2050?
- Technologies changing R&D approaches
- Clinical trial designs and regulatory evolution
- Reimbursement models
- Delivering global healthcare equity
Changeover Video
Fireside Chat: What Has Surprised Us Most in the Past 25 Years?
Changeover Video
Keynote Panel: Has the Past 25 Years of Life Sciences R&D Delivered on Expectations?
- What was the ambition in year 2000?
- Was it achieved?
- If not, why not?
- What provides optimism by 2050?
Changeover Video
Closing Remarks
Drinks Reception
Close
Programme is subject to change